Valeo Pharma Inc (VPH.TO)
0.10
0.00 (0.00%)
CAD |
TSX |
May 08, 16:00
Valeo Pharma Shareholders Equity (Quarterly): -47.01M for Jan. 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | -47.01M |
| October 31, 2023 | -40.34M |
| July 31, 2023 | -35.05M |
| April 30, 2023 | -29.16M |
| January 31, 2023 | -23.57M |
| October 31, 2022 | -17.85M |
| July 31, 2022 | -6.907M |
| April 30, 2022 | -3.17M |
| January 31, 2022 | 0.615M |
| October 31, 2021 | 2.053M |
| July 31, 2021 | 9.827M |
| Date | Value |
|---|---|
| April 30, 2021 | 1.543M |
| January 31, 2021 | 2.269M |
| October 31, 2020 | 3.069M |
| July 31, 2020 | -2.121M |
| April 30, 2020 | -1.611M |
| January 31, 2020 | -1.085M |
| October 31, 2019 | -0.022M |
| July 31, 2019 | 1.362M |
| April 30, 2019 | -2.126M |
| January 31, 2019 | -2.389M |
| October 31, 2018 | -1.367M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-47.01M
Minimum
Jan 2024
9.827M
Maximum
Jul 2021
-9.850M
Average
-1.611M
Median
Apr 2020
Shareholders Equity (Quarterly) Benchmarks
| Biocure Technology Inc | 2.586M |
| Core One Labs Inc | 5.641M |
| Nova Mentis Life Science Corp | -0.601M |
| Nanosphere Health Sciences Inc | -2.014M |
| Lobe Sciences Ltd | -0.6811M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 40.35M |
| Total Liabilities (Quarterly) | 87.37M |
| Debt to Equity Ratio | -1.369 |
| Current Ratio | 0.4855 |
| Net Debt Paydown Yield | -2.76% |